Your institution may have access to this item. Find your institution then sign in to continue.
Title
(Mis)treating the pharmacogenetic incidentalome.
Authors
Kohane, Isaac S
Abstract
Genome-wide screening is anticipated to accelerate the development of personalized medicine by identifying and exploiting new associations between genomic variants and drug responses. However, this goal could be undermined if care is not taken to minimize the impact of pharmacogenomic associations that turn out to have narrower implications than suggested by initial studies.
Publication
Nature reviews. Drug discovery, 2012, Vol 11, Issue 2, p89